{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:23:03Z","timestamp":1793240583327,"version":"4.5.0"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,12,1]]},"DOI":"10.1001\/jamadermatol.2021.4082","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T18:36:37Z","timestamp":1636569397000},"page":"1411","source":"Crossref","is-referenced-by-count":4,"title":["Novel Treatments for Chronic Erythema Multiforme Inform Translational Science and Disease Pathogenesis"],"prefix":"10.1001","volume":"157","author":[{"given":"Arturo R.","family":"Dominguez","sequence":"first","affiliation":[{"name":"Departments of Dermatology and Internal Medicine, The University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha N.","family":"Lopez","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical School, The University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"ded210016r1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaad.2009.06.046","article-title":"Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007.","volume":"62","author":"Wetter","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"ded210016r2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/ijd.2012.51.issue-8","article-title":"Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist.","volume":"51","author":"Sokumbi","year":"2012","journal-title":"Int J Dermatol"},{"issue":"2","key":"ded210016r3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/ewjm.172.2.124","article-title":"Emotional dimensions of chronic disease.","volume":"172","author":"Turner","year":"2000","journal-title":"West J Med"},{"issue":"1","key":"ded210016r4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/1523-1747.ep12277397","article-title":"Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme.","volume":"93","author":"Brice","year":"1989","journal-title":"J Invest Dermatol"},{"issue":"4","key":"ded210016r5","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/bjd.2006.155.issue-4","article-title":"Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome\/toxic epidermal necrolysis.","volume":"155","author":"Caproni","year":"2006","journal-title":"Br J Dermatol"},{"key":"ded210016r6","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2021.4083","article-title":"Evaluation of thalidomide treatment for patients with chronic erythema multiforme: a multicenter retrospective cohort study.","author":"Roux","year":"2021","journal-title":"JAMA Dermatol"},{"key":"ded210016r7","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2021.4084","article-title":"Treatment of persistent erythema multiforme with Janus kinase inhibition and the role of interferon gamma and interleukin 15 in its pathogenesis.","author":"Murphy","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"2","key":"ded210016r8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jdcr.2016.11.009","article-title":"Treatment of recurrent erythema multiforme with adalimumab as monotherapy.","volume":"3","author":"Baillis","year":"2017","journal-title":"JAAD Case Rep"},{"issue":"1","key":"ded210016r9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5070\/D37V35W30D","article-title":"Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component.","volume":"9","author":"Aurelian","year":"2003","journal-title":"Dermatol Online J"},{"issue":"6","key":"ded210016r10","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jdcr.2016.10.009","article-title":"Idiopathic erythema multiforme: Evidence of underlying Janus kinase-signal transducer and activator of transcription activation and successful treatment with tofacitinib.","volume":"2","author":"Damsky","year":"2016","journal-title":"JAAD Case Rep"},{"issue":"5","key":"ded210016r11","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.18256","article-title":"Image gallery: tofacitinib for treatment of herpes-associated erythema multiforme.","volume":"181","author":"von Csiky-Sessoms","year":"2019","journal-title":"Br J Dermatol"},{"issue":"10","key":"ded210016r12","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.4049\/jimmunol.171.10.5313","article-title":"STAT-1 alpha and IFN-gamma as modulators of TNF-alpha signaling in macrophages: regulation and functional implications of the TNF receptor 1:STAT-1 alpha complex.","volume":"171","author":"Wesemann","year":"2003","journal-title":"J Immunol"},{"key":"ded210016r13","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620950831","article-title":"The role of IL-13, IL-15 and granulysin in the pathogenesis of Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis.","volume":"27","author":"Sadek","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"issue":"19","key":"ded210016r14","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease.","volume":"382","author":"Zeiser","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"ded210016r15","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jid.2016.11.034","article-title":"Interleukin-15 is associated with severity and mortality in Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis.","volume":"137","author":"Su","year":"2017","journal-title":"J Invest Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2785839\/jamadermatology_dominguez_2021_ed_210016_1639533868.37702.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T21:33:55Z","timestamp":1673732035000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2785839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.4082","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}